Allergopharma Joachim Ganzer KG, Pharmacia & Upjohn Diagnostics AB deal

Allergopharma received an option to acquire co-exclusive rights to immunotherapeutic applications of P&U. s non-aliphatic forms of recombinant birch pollen allergen. Allergopharma will conduct Phase I...